|
||
| |||||||
|
The BioTech Sage Report is a newsletter that is published monthly. The report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities. Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioTech Sage Report is to keep our subscribers abreast of the ever changing and advancing field of biotechnology, with the basic belief that an informed investor is a successful stock investor. We will discuss recent discoveries, their commercial implications and what developments wait. Each issue examines the biotech companies or pharmaceuticals that is related to our topic of the month and we also cover specific companies that we feel have great long-term appreciation. The report is an information integrator that provides you a wealth of information and ideas. Plus, we work hard at it. Positive or negative, BioTech Sage Report gives the reader the facts! So why subscribe to BioTech Sage Report? The biotechnology sector is an exciting, yet complex and risky investment arena and assessing the scientific basis of new technology requires specialized knowledge. The report is a focused and an in depth source of information allowing investor to have the upper hand when it comes to investing in biotechnology stocks. Think of us as your research laboratory on biotechnology stocks. In each issue of our report, we cover a specific topic such as a condition or disease with a discussion of new or current technologies in layman's language. BioTech Sage Report features publicly traded biotechnology, pharmaceutical, supplies, services and medical-related companies. We provide investors with unique insight into an industry where there is significant growth potential, driven by high demand and lucrative profits. BioTech Sage Report provides comprehensive analysis, interpretation, news and commentary for the biotechnology, pharmaceuticals and medical and other related industries. It is committed to give you the essential data you need to make intelligent informed investment decisions. We do the dirty work necessary for proper investing in securities that most individual investors don't bother to do either because it is too tedious or because they don't understand how to do it. Using fundamental and technical calculations we find some of the best ideas for long-term investment strategies. BioTech Sage Report is geared for those who are serious about investing in biotech stocks. Our research is independent and unbiased. Publisher: Biotech Sage To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Bioportfolio_Biotech_Sage_34.html#a235
|
|
| ||||||||